Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kaleida Capital is a venture capital firm founded by Dr. Ariane Tom, based in the United States. The firm focuses on neurotechnology and artificial intelligence, aiming to support advancements in brain-inspired technologies and precision medicine. Specific investment areas include neural data infrastructure and human performance.
Kaleida Capital invests in early-stage companies within the neurotechnology and AI sectors, particularly those developing neural engineering, brain-computer interfaces, and deep AI applications. The firm targets pre-seed to Series A stages, seeking to back breakthrough technologies that enhance human abilities.
Kaleida Capital's portfolio features notable companies such as a computational neuroimaging platform for drug development in schizophrenia and bipolar disorders, and a company innovating wireless power delivery for implanted medical devices. Other highlights include a brain-computer interface technology for restoring speech and motor function, a leading generative AI research firm backed by Amazon, and a prosthetic retina for vision restoration in macular degeneration patients.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.